Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson’s Disease

Scientific Reports - United Kingdom
doi 10.1038/srep34478
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Engineering Therapeutic Neural Stem Cell Lines for Parkinson’s Disease

2011English

Cell Therapy for Macular Degeneration—first Phase I/Ii Pluripotent Stem Cell-Based Clinical Trial Shows Promise

Science China Life Sciences
GeneticsMolecular BiologyEnvironmental ScienceBiochemistryBiological SciencesAgricultural
2014English

Cell Therapy for Parkinson’s Disease With Induced Pluripotent Stem Cells

Clinical Neurology
Neurology
2019English

Neural Networks and Neurofeedback in Parkinson’s Disease

NeuroRegulation
Mental HealthNeuropsychologyCognitive PsychologyPhysiological PsychologyApplied PsychologyNeurologyBehavioral NeurosciencePsychiatryBiological PsychiatryPhysiologyExperimental
2014English

Phase I Clinical Trial of Temsirolimus and Perifosine for Recurrent Glioblastoma

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2020English

Lithium Chloride Promotes Neuronal Differentiation of Rat Neural Stem Cells and Enhances Neural Regeneration in Parkinson’s Disease Model

Cytotechnology
Clinical BiochemistryBioengineeringBiomedical EngineeringCell BiologyBiotechnology
2017English

How I Do It: The Neuro-Ophthalmological Assessment in Parkinson’s Disease

Journal of Parkinson's Disease
Molecular NeuroscienceNeurologyCellular
2019English

Notching Up Neural Stem Cell Homogeneity in Homeostasis and Disease

Frontiers in Neuroscience
Neuroscience
2014English

Developing Stem Cell Therapies for Parkinson’s Disease: Waiting Until the Time Is Right

Cell Stem Cell
Molecular MedicineGeneticsCell Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy